alpha-Interferon potentiates epidermal growth factor receptor-mediated effects on human epidermoid carcinoma KB cells

Int J Cancer. 1995 May 4;61(3):342-7. doi: 10.1002/ijc.2910610312.

Abstract

The molecular mechanisms underlying the growth inhibition of human tumor cells induced by recombinant interferon-alpha (IFN alpha) are mostly unknown. It has been proposed that this effect could be related to down-regulation and/or impaired function of peptide growth factor receptors (PGF-Rs) in tumor cells exposed to IFN alpha. However, we have previously described that IFN alpha-induced growth inhibition of human epidermoid carcinoma cells is paralleled by up-regulation of epidermal growth factor receptor (EGF-R). Here we report that an increase in EGF-R synthesis is detectable after 3 hr of exposure to cytostatic concentration of IFN alpha in epidermoid KB tumor cells. In these experimental conditions IFN alpha does not depress and even potentiates EGF-R function. IFN alpha-treated KB cells retain sensitivity to the cytotoxic activity of the anti-EGF-R 225 monoclonal antibody (MAb), which acts through receptor blockade, and are sensitized to the growth-promoting effect of EGF. EGF-induced tyrosine (tyr) phosphorylation both of total cellular protein extracts and of the immunoprecipitated EGF-R is increased in IFN alpha-treated cells. We conclude that a cross-talk between IFN alpha and EGF occurs in KB cells since IFN alpha, at cytostatic concentration, potentiates the effects mediated by the EGF-R.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Carcinoma, Squamous Cell
  • Cell Division / drug effects
  • Epidermal Growth Factor / metabolism
  • Epidermal Growth Factor / pharmacology*
  • ErbB Receptors / biosynthesis*
  • ErbB Receptors / drug effects
  • ErbB Receptors / metabolism
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / pharmacology*
  • KB Cells
  • Kinetics
  • Molecular Weight
  • Recombinant Proteins
  • Time Factors
  • Up-Regulation

Substances

  • Antibodies, Monoclonal
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Epidermal Growth Factor
  • ErbB Receptors